G. Marchesini et al., Cardiovascular disease in cirrhosis - A point-prevalence study in relationto glucose tolerance, AM J GASTRO, 94(3), 1999, pp. 655-662
OBJECTIVE: Impaired glucose tolerance or diabetes are frequently observed i
n cirrhosis. Overt diabetes was reported to affect long term survival of ci
rrhotic patients by increasing the risk of hepatocellular failure, without
increasing the risk of diabetes-associated cardiovascular events.
METHODS: We evaluated the prevalence of cardiovascular disease in 122 patie
nts with cirrhosis, subdivided according to their glucose tolerance. The fo
llowing parameters were considered: arterial pressure, peripheral vascular
disease (ankle to brachial pressure ratio), ischemic heart disease, microal
buminuria, retinopathy. The prevalence of abnormal findings was compared wi
th that observed in 60 randomly selected patients with non-insulin-dependen
t diabetes and in 40 controls.
RESULTS: Noninsulin-dependent diabetic patients and patients with cirrhosis
and diabetes were comparable for age, metabolic control, and smoking habit
s; the duration of diabetes was 5 yr longer for noninsulin-dependent diabet
es. In cirrhosis, the prevalence of micro- and peripheral macroangiopathy,
as well as coronary heart disease, was not different in relation to glucose
tolerance, it was comparable to that of controls, and significantly lower
than that observed in noninsulin-dependent diabetes.
CONCLUSIONS: Cirrhotic patients, even in the presence of overt diabetes, ar
e at low risk of cardiovascular disease. The low prevalence may be related
to shorter duration of diabetic disease, also in relation to reduced life e
xpectancy, as well as to liver disease-induced abnormalities protecting the
cardiovascular system from atherosclerosis. (Am J Gastroenterol 1999;94:65
5-662. (C) 1999 by Am. Cell. of Gastroenterology).